The layoffs are slated to shrink the newsroom by hundreds of journalists, cutting into The Post’s local, international and sports coverage.
New tools by artificial intelligence companies like Anthropic have reignited worries that businesses will pare down their subscriptions to software services.
The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry and faces lower prices for its medicines under a deal with President Trump.
The year-old company, founded by veterans of the autonomous vehicle business Waymo, is seeking to automate excavators and other building equipment.
The company reported total revenue of $802.3 million for the fourth quarter of 2025, up 10.4 percent from a year earlier.
Is this the year the internet changes forever?
In a country roiled by political upheaval recently, retiring the longtime currency, the lev, prompted some concern about inflation but little other angst.
The league is so important to the business of media companies that they are likely to have little choice but to agree to renegotiations.
Concerns about defaults, particularly among software companies, have spooked investors in the private credit firms that lend to them.
Couples have three days to celebrate togetherness this year, and resorts and hotels are going all out on the feel-good front.
When President Trump said he wanted to drive housing prices up, not down, he was speaking to a conundrum that has flummoxed policymakers for decades.
Bipartisan Senate and House packages, aimed at rewarding new construction and eliminating red tape, could bring significant changes to federal housing laws.
The U.S. claim on Venezuela’s oil means even more of it could come to a huge Chevron refinery. Neighbors worried about pollution want the company to buy their homes.
On The Times’s Visual Investigations team, Christiaan Triebert combines social media sleuthing and traditional reporting to piece together complex stories.
The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits.
Experts are reaching to divine the president’s approach to global policy and economics, with one theory seeing antecedents in centuries-old dynastic rule.
The organization’s latest guidance is a departure from the prevailing views of several other major medical organizations.
Senators asked Ted Sarandos about whether the acquisition would raise prices, squeeze talent and degrade the moviegoing experience.
Mr. Miran had taken a leave of absence from advising the president after adding a role at the Federal Reserve, drawing criticism from Democrats.
The show on Sunday drew about 14.4 million people. It is the second consecutive year that the awards ceremony attracted a smaller audience.
Tyson Foods said its beef business could lose up to $500 million this year as the supply of cattle hits a 75-year low.
She fished off the New England coast for more than 80 years, and intended to continue until she died. “It’s not hard work for me,” she said at 101.
The company’s rapid e-commerce growth and push into automation and artificial intelligence propelled its stock into the trillion-dollar club.
In a legal first, a jury in New York awarded $2 million to a patient who said that doctors had deviated from accepted medical standards.
The N.F.L. claims Guardian Caps reduce the risk of concussions. The company that makes them says, “It has nothing to do with concussions.”
A group of cryptocurrency investors backing a memecoin hopes the statue will soon be installed at one of Mr. Trump’s golf courses in Florida.
Jeffrey Epstein wanted most of his money to go to his girlfriend, a native of Belarus. Mr. Epstein’s brother and a Harvard math professor were also named beneficiaries.
The move followed a yearlong investigation into X and escalated a wider standoff between European officials and American tech companies over the regulation of social media.
Parasites and infections that cause blindness and other disabilities were nearly eliminated in some countries, but drug distribution to prevent and treat them was derailed in many places in 2025 after the U.S. cut aid.
Ms. Tanner was previously an executive at CBS News and serves on the board of Audacy, a major U.S. broadcaster and podcast producer.
Ms. Tanner was previously an executive at CBS News and serves on the board of Audacity, a major U.S. broadcaster and podcast producer.